Role of HDAC3 on p53 Expression and Apoptosis in T Cells of Patients with Multiple Sclerosis
2011

Role of HDAC3 on p53 Expression and Apoptosis in T Cells of Patients with Multiple Sclerosis

Sample size: 34 publication 10 minutes Evidence: moderate

Author Information

Author(s): Zhang Fanglin, Shi Yaping, Wang Lily, Sriram Subramaniam

Primary Institution: Vanderbilt University Medical Center

Hypothesis

Increased expression of HDAC3 in T cells may contribute to autoimmunity in multiple sclerosis patients.

Conclusion

MS patients show increased expression of HDAC3 and reduced sensitivity to TSA-induced apoptosis in T cells.

Supporting Evidence

  • HDAC3 expression was significantly higher in MS patients compared to healthy controls.
  • MS patients showed reduced sensitivity to TSA-induced apoptosis.
  • Induction of p53 was observed in healthy controls but not in MS patients.

Takeaway

This study found that people with multiple sclerosis have more of a protein called HDAC3, which makes their immune cells less likely to die when they should, possibly leading to more problems with their immune system.

Methodology

Gene expression profiles were compared between MS patients and healthy controls using microarray analysis and flow cytometry.

Potential Biases

Potential bias due to the small sample size and the specific population studied.

Limitations

The study included a small number of patients for some treatment groups, which may limit the generalizability of the findings.

Participant Demographics

34 patients with clinically definite MS and 33 healthy volunteers, including various subtypes of MS.

Statistical Information

P-Value

0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016795

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication